What a nutraceutical marketing agency actually does — and how to pick one

Why nutraceutical marketing is its own discipline

Selling a protein powder or a gut-health supplement online in India is not FMCG marketing with different packaging. Three things change the game. First, claims are regulated: FSSAI's nutraceutical regulations decide what may appear on your label and, in practice, in your ads. Second, the platforms police health aggressively – Meta and Google reject or restrict supplement ads at a rate no snack brand ever sees. Third, the economics run on repeat purchase: a customer who buys one jar and leaves usually loses you money, so CAC has to be underwritten by LTV, not first-order ROAS.

An agency that has only run fashion or food will discover each of these the expensive way, on your ad account and your money.

The category context makes it harder still: nutraceuticals have become one of Indian D2C's most crowded spaces – protein, collagen, gut health, sleep, ayurvedic-modern hybrids – so ad costs behave like a hot auction while the claim rules behave like a minefield. The brands compounding in 2026 treat compliance as a growth asset: cleared claims move faster, scale further, and never restart from a banned account.

The compliance layer decides your ceiling

Before anyone opens Ads Manager, the claims question has to be settled. Under FSSAI's framework for health supplements and nutraceuticals, disease-treatment claims – cures, prevents, treats – are off the table; permitted claims are essentially nutrition and function claims that you can substantiate. We've written the full breakdown in what supplement brands can legally claim.

The part most brands miss: your website is part of your ad. Platform reviewers and regulators read your landing pages, product pages and reviews, not just the ad creative. A compliant ad pointing to a page that says "reverses diabetes" is a restricted account waiting to happen. A serious agency audits the whole surface – ads, PDPs, packaging renders, even auto-published review widgets – before scaling spend.

Working examples of the line: "supports daily energy", backed by a recognised nutrient function, is workable; "cures fatigue" is not. "24g protein per serving" is a substantiated nutrition claim; "builds muscle in 30 days" is an outcome promise you will be asked to prove. The craft is precision, not timidity – the compliant version of a claim is usually the more specific one.

Why nutra ad accounts keep getting restricted

The rejection patterns are consistent: before/after imagery, personal-attribute callouts ("struggling with PCOS?"), unrealistic outcome promises, and medical terminology that trips Meta's health classifiers. Repeated rejections compound into account-level restrictions, and most brands respond by launching new ad accounts – which the platform treats as evasion, making the hole deeper. We've documented the pattern (and the way out) in why Meta rejects ayurvedic ads; the mechanics for nutraceuticals are nearly identical.

The durable fix is upstream: rewrite the claims layer so ads, landing pages and product pages all pass review on their own merits. It is slower than spinning up a fresh account. It is also the only version that survives scale.

There's a compounding cost hiding here too: every rejected ad delays learning. Accounts shipping compliant creative from day one gather conversion data continuously, while restricted accounts spend weeks in review purgatory relearning what the algorithm already knew about their audience.

What a nutraceutical agency should actually do for you

If you're evaluating agencies for a supplement brand, the scope should look like this:

• Claims audit first: every ad, PDP and label claim mapped against FSSAI rules and platform policy before new creative is made.
• Benefit language that converts without disease claims: outcomes framed around energy, routine, ingredients and evidence – the craft is selling hard inside the lines.
• Landing pages built for consideration: supplements are researched purchases; ingredient transparency, dosage clarity and social proof do the convincing that claims cannot.
• Subscription and retention economics: CAC targets set against 6–12 month LTV, with retention flows treated as a first-class channel.
• Marketplace and quick-commerce strategy: a large share of Indian supplement demand converts on Amazon and q-commerce, and your D2C ads feed those searches.
• Reporting on delivered, prepaid revenue – not platform-reported ROAS alone.

Notice what's missing from that list: hacks. No agency-side trick – cloaked links, rotating ad accounts, review-dodging landing pages – survives contact with 2026-era platform enforcement, and every one of them puts the brand asset at risk. If a pitch leans on workarounds rather than claims discipline, you're hiring your next crisis.

Proof the compliant route scales

The instinct is that compliance caps growth. The record says otherwise: constraint forces better marketing. In an adjacent regulated-adjacent category – organic food, where claims scrutiny is similarly unforgiving – we took Pro Nature from 1.2× to 8× ROAS over 10 months with exactly this sequence: fix the claims and the story first, then scale spend into creative that passes review every time. The brands that get banned aren't the ambitious ones; they're the impatient ones.

When you evaluate any agency's nutra case studies, ask the same three questions: was the growth built on compliant creative, or on claims that have since been scrubbed; did the ad account survive the scaling; and did repeat purchase hold once launch discounting stopped? A ROAS number without those three answers is decoration.

Where The Shizz fits — and where we don't

Full disclosure: this is our blog. The Shizz is a D2C growth agency (Bangalore and Kolkata, running since 2020) specialising in FMCG, F&B, nutrition and consumer goods – 160+ brands, ₹150 Cr+ of ad spend managed, ₹450 Cr+ in attributed revenue. Nutraceuticals sit squarely inside that focus, and the compliance-first playbook above is the one we actually run.

Where we're the wrong fit, honestly: licensed pharmaceutical products, B2B ingredient suppliers, clinics and practitioner-led services, and brands not yet doing meaningful monthly revenue – agency economics won't work for you yet, and we'll say so. If you want the claims-and-account diagnosis before committing to anyone, start with a free Growth Audit.